Nomination Summary for Flurazepam (N86331)
Nominated Substances: Flurazepam
Nomination Date: 03/00/1986
Nominator: FDA
Rationale: Flurazepam has extensive use and human exposure; lack of carcinogenicity data in rodents.
Nominated Substances: Flurazepam
Nomination Date: 03/00/1986
Nominator: FDA
Rationale: Flurazepam has extensive use and human exposure; lack of carcinogenicity data in rodents.